Reducing COPD flare-ups with pneumonia germ treatment
Treatments studied
Part of Lungs & breathing clinical trials.
This study tests whether treating a specific germ (Pneumocystis jirovecii) in the lungs can reduce the number of COPD flare-ups. If you have COPD with frequent flare-ups and this germ is found in your sputum, you may benefit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older.
- You have COPD diagnosed by a breathing test and have had at least 1 moderate or severe flare-up in the last year.
- You have been on a stable triple inhaler (or two inhalers if one is not right for you) for at least 1 month.
- A test of your sputum shows a germ called Pneumocystis jirovecii.
- You are not allergic to certain antibiotics (TMP-SMX or sulfa drugs) and have no other infections or conditions that would interfere.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment for people with COPD who still have frequent flare-ups despite using two maintenance inhalers. It aims to see if the study medicine can reduce these flare-ups.
This study tests whether using a blood test called CRP can help doctors decide when antibiotics are needed during a COPD flare-up. It may reduce unnecessary antibiotics while still treating infections when they’re likely.
This study tests an experimental drug called JKN2403 for people with moderate to severe COPD. It aims to see if the drug can reduce flare-ups and improve breathing compared to a placebo (a dummy pill).
This Phase 3 study tests whether low-dose trimethoprim-sulfamethoxazole (also called TMP-SMX) can treat Pneumocystis pneumonia (PCP) in people with weakened immune systems. It may help improve treatment while reducing side effects compared with standard dosing.
This trial tests a new way to diagnose and treat chronic obstructive pulmonary disease (COPD) flare-ups (sudden worsening of symptoms). It aims to help people who come to the emergency room with a COPD flare-up get better care and follow-up.
This trial tests whether a preventive treatment can stop pneumocystis pneumonia (a lung infection) in people with autoimmune inflammatory rheumatic diseases who are taking steroids or other immune-suppressing medicines. It aims to find the safest and most effective way to protect you from this serious infection.
Hear when a new Chronic Obstructive Pulmonary Disease (COPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.